Novo Holdings

Private and public venture investing Supporting high-growth life science companies Sizable investments in leading life science companies Our investments outside the life sciences We are the holding company of the Novo Group and manage the wealth of the Novo Nordisk Foundation We invest in life science companies at all stages of development and in a broad portfolio of equity and fixed income securities, as well as real assets (real estate and infrastructure) For more information, download our fact sheet

Our people embrace a culture of high performance with high responsibility

Novo Holdings employs investment and business professionals focused on delivering attractive returns for the benefit of the Novo Nordisk Foundation

• A values-based company: The Novo Holdings Way
• We strive for high performance with high responsibility
• Ensuring solid foundations for success
• A cohesive and strong Leadership Team

We aspire to be a leading global responsible investor delivering attractive long-term returns and positive societal impact

Responsible Investments at Novo Holdings

We aspire to become catalysts of change by investing in companies that – like Novo Holdings – believe that there are achievable solutions to the pressing challenges facing both humankind and our planet Read more

• € 96 bn Total investment assets of Novo Holdings at the end of 2021

Total investment assets of Novo Holdings at the end of 2021

• 14 % Return on Life Science investments last 5 years

Return on Life Science investments last 5 years

• 9 % Return on Capital investments last 5 years

Return on Capital investments last 5 years

Novo Ventures (US) Inc * 200 Clarendon Street, Floor 45 Boston, MA 02116 USA Novo Ventures (US) Inc * 501 2nd Street, Suite 300 San Francisco, CA 94107 USA +1 (415) 552-6686 Novo Holdings Equity Asia Pte Ltd * 6 Battery Road #23-03 Singapore 049909 Singapore Novo Holdings Equity US Inc * 501 2nd Street, Suite 300 San Francisco, CA 94107 USA +1 (415) 552-6686 Novo Holdings Equity US Inc * 200 Clarendon Street, Floor 45 Boston, MA 02116 USA Media Relations Christian Mostrup Scheel Senior Press Officer cims@novo dk +45 3067 4805

• Novo Ventures (US) Inc , Novo Holdings Equity US Inc , comprising Novo Growth and Principal Investments, and Novo Holdings Equity Asia Pte Ltd are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech companies in the US as well as certain follow-up activities related thereto, such as board memberships, financial control and reporting efforts